Inventor · disambiguated record
Shailaja Kasibhatla
Also filed as: KASIBHATLA SHAILAJA
23 granted patents·22 pending applications·325 citations·filing 2000–2025
95Inventor score
Top patents by PatentIndex Score
45 records- 0195US7041685B2Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted May 9, 2006·118 cites·12 claims
- 0293US7435750B2Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2005·Granted Oct 14, 2008·30 cites·12 claims
- 0393US6462041B1Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2000·Granted Oct 8, 2002·44 cites·54 claims
- 0492US7618975B24-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofMYRIAD PHARMACEUTICALS INC·Filed 2004·Granted Nov 17, 2009·61 cites·48 claims
- 0590US11666579B2Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2020·Granted Jun 6, 2023·2 cites·21 claims
- 0688US11634497B2Anti-CCR7 antibody drug conjugatesNOVARTIS AG·Filed 2018·Granted Apr 25, 2023·5 cites·26 claims
- 0787US6613762B2Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2002·Granted Sep 2, 2003·18 cites·22 claims
- 0884US10973826B2Antibody conjugates comprising toll-like receptor agonistCORTEZ ALEX·Filed 2016·Granted Apr 13, 2021·6 cites·28 claims
- 0982US11752162B2Compounds and compositions for treating solid tumors by intratumoral administrationNOVARTIS AG·Filed 2018·Granted Sep 12, 2023·1 cites·21 claims
- 1082US11628172B2Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2020·Granted Apr 18, 2023·1 cites·25 claims
- 1178US12396995B2Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined useCELGENE CORP·Filed 2023·Granted Aug 26, 2025·0 cites·34 claims
- 1278US10195208B2Combination therapyNOVARTIS AG·Filed 2015·Granted Feb 5, 2019·5 cites·26 claims
- 1378US2025352551A1Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined useCELGENE CORP·Filed 2025·Application pending·0 cites
- 1476US12178822B2Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dionCELGENE CORP·Filed 2023·Granted Dec 31, 2024·0 cites·26 claims
- 1574US7176234B2Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Feb 13, 2007·8 cites·45 claims
- 1674US2024009215A1Compounds and compositions for treating solid tumors by intratumoral administrationNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1773US6794400B24-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Sep 21, 2004·7 cites·11 claims
- 1872US7135480B2Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Nov 14, 2006·6 cites·21 claims
- 1972US6828091B2Method of identifying immunosuppressive agentsCYTOVIA INC·Filed 2001·Granted Dec 7, 2004·10 cites·24 claims
- 2069US12180291B2Anti-CCR7 antibody drug conjugatesNOVARTIS AG·Filed 2023·Granted Dec 31, 2024·0 cites·17 claims
- 2169US7592143B2Methods of treating diseases responsive to induction of apoptosis and screening assaysCYTOVIA INC·Filed 2004·Granted Sep 22, 2009·3 cites·9 claims
- 2268US11583536B2Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined useCELGENE CORP·Filed 2020·Granted Feb 21, 2023·0 cites·41 claims
- 2368US2023210859A1Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2023·Application pending·0 cites
- 2462US7074813B2Substituted N′-(arylcarbonyl)-benzhydrazides, N′-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Granted Jul 11, 2006·0 cites·10 claims
- 2562US2021346387A1Antibody conjugates comprising toll-like receptor agonistNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2661US2008032974A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 2761US2008039479A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 2860US2023272485A1Replication stress pathway agent compositions and methods for treating cancerBOUNDLESS BIO INC·Filed 2023·Application pending·0 cites
- 2960US2007249601A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3060US2007244113A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3159US2007208044A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 3257US2008045514A13-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3356US2007043076A1Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosisCAI SUI X·Filed 2004·Application pending·0 cites
- 3455US2017050937A1Compounds and therapeutical use thereofImmune pharmaceuticals inc·Filed 2016·Application pending·0 cites
- 3552US2021116454A1Methods for treating a hematological cancer and the use of companion biomarkers for 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2020·Application pending·0 cites
- 3651US7968595B2Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereofCYTOVIA INC·Filed 2007·Granted Jun 28, 2011·0 cites·36 claims
- 3749US7256219B2Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Aug 14, 2007·0 cites·8 claims
- 3849US2005004005A1Methods of treating diseases responsive to Induction of ApoptosisFiled 2004·Application pending·0 cites
- 3949US2021170043A1Dc-sign antibody conjugates comprising sting agonistsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4046US2007244114A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 4142US2003027229A1Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosisCYTOVIA INC·Filed 2002·Application pending·0 cites
- 4241US2005165053A1Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Application pending·0 cites
- 4341US2020164084A1Antibody conjugates comprising toll-like receptor agonist and combination therapiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 4438US2019167694A1New therapeutics usesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 4531US2018177872A1Combination of PD-1 antagonist with an EGFR inhibitorJIA YONG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shailaja Kasibhatla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →